Yusuke Sato

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 5

Top Topics

Patient Reported Outcomes

Contrast Enhanced Ultrasound

Peripheral Artery Disease

Top Venues

Journal of cardiovascular pharmacology and therapeutics

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists

ESC heart failure

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions

This page only lists publications with an associated author ORCID identifier.

Publications

Yusuke Sato, Tetsuji Morishita, Tomohiro Shimizu, Tatsuhiro Kataoka, Yuya Matsunaka, Hiroyasu Uzui, Hiroshi Tada
Evaluation of nontarget lesions in femoropopliteal disease using near-infrared spectroscopy intravascular ultrasound imaging. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2024)
Ryohei Nomura, Tetsuji Morishita, Yusuke Sato, Daisetu Aoyama, Tomohiro Shimizu, Hiroyasu Uzui, Akira Nakano, Hiroshi Tada
Effects of door-to-tolvaptan time on short-term clinical outcome in patients with acute heart failure. ESC heart failure (2023)
Yusuke Sato, Kazushi Urasawa, Michinao Tan, Taichi Hayashi, Takashi Miwa
A novel endovascular method of atherectomy for calcified common femoral and popliteal disease using the crosser system: Crossbow and Rambow techniques. Vascular (2022)
Michinao Tan, Kazushi Urasawa, Yusuke Sato, Takashi Miwa, Taichi Hayashi
Parallel Wiring Using a Single Intravascular Ultrasound Catheter with Double Rapid Exchange Lumens Technique for Chronic Total Occlusions in Peripheral Artery Disease. Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2021)
Yusuke Sato, Hiroyasu Uzui, Moe Mukai, Yuichiro Shiomi, Kanae Hasegawa, Hiroyuki Ikeda, Naoto Tama, Yoshitomo Fukuoka, Tetsuji Morishita, Kentaro Ishida, Kenichi Kaseno, Shinsuke Miyazaki, Akira Nakano, Hiroshi Tada
Efficacy and Safety of Tolvaptan in Patients More Than 90 Years Old With Acute Heart Failure. Journal of cardiovascular pharmacology and therapeutics 25 (1) (2019)